Sort
39,280 grants matching “leukemia”
LANGERHANS CELL REPLACEMENT FOLLOWING ALLOGENIC STEM CELL TRANSPLANTATION
$438,636Edgar G. Engleman · Stanford University · P01 · FY2007 · HL
The role of H3K79 methylation in IDH-mutant leukemia
$438,616Kathrin M Bernt · Children'S Hosp Of Philadelphia · R01 · FY2018 · CA
Regulation of neutrophil function by ROS-induced actin glutathionylation
$438,542Hongbo R Luo · Boston Children'S Hospital · R01 · FY2014 · AI
A stalled chromatin regulatory network that mediates the oncogenic activity of Meningioma-1
$438,480Kathrin M Bernt · Children'S Hosp Of Philadelphia · R01 · FY2025 · CA
Studies of other risk factors for radiosensitive tumors
$438,440Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
DRUG METABOLISM IN CHILDHOOD CANCER
$438,416St. Jude Children'S Research Hospital · R37 · FY2000 · CA
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$438,385Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
MURINE MODELS OF MYELOID MALIGNANCIES
$438,352D Gary Gilliland · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Circadian interventions against glioblastoma
$438,347Erik Herzog · Washington University · R01 · FY2024 · NS
Targeting EWS-ATF1 Fusion in Clear Cell Sarcoma of Soft Tissue
$438,334Bingbing Li · Oregon Health & Science University · R01 · FY2023 · CA
NOVEL ANTITUMOR DISULFIDES
$438,319Prolx Pharmaceuticals, Lp · R44 · FY2001 · CA
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
$438,242Srividya Swaminathan · Beckman Research Institute/City Of Hope · R37 · FY2025 · CA
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
$438,242Srividya Swaminathan · Beckman Research Institute/City Of Hope · R37 · FY2023 · CA
Interactions of Retroviral Proteins with Nucleic Acids
$438,229Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Retrovirus Assembly and Maturation
$438,229Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Core A: Single Cell Profiling and Bioinformatics Core
$438,166Koichi Takahashi · Baylor College Of Medicine · P01 · FY2024 · CA
Project 4: Tumorigenic Effects of Tax
$438,117Lee Ratner · Ohio State University · P01 · FY2018 · CA
Pharmacogenetic Determinants of Vincristine Toxicity and Response
$438,042Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2011 · HD
Investigations of menin function in Ewing sarcoma
$438,039Elizabeth R Lawlor · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Functional Study of Native and Synthetic Nuclei
$438,003Douglass J Forbes · University Of California, San Diego · R01 · FY2007 · GM
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD
$438,002University Of North Carolina Chapel Hill · R01 · FY2004 · CA
Risk for Psychopathology and Neurocognitive Impairment in Leukemia Survivors
$437,954Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2010 · MH
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$437,922David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Project 1 - Genomics of Intermediate-Risk AML Progression and Relapse.
$437,796Timothy J Ley · Washington University · P01 · FY2021 · CA
Interplay Between Cancer and Immune Cells on Targeted Therapy
$437,707Peter Poon-Hang Lee · Stanford University · R01 · FY2009 · CA